Massimo Mattioli

463 total citations
15 papers, 259 citations indexed

About

Massimo Mattioli is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Massimo Mattioli has authored 15 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Pathology and Forensic Medicine and 4 papers in Infectious Diseases. Recurrent topics in Massimo Mattioli's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Systemic Sclerosis and Related Diseases (5 papers) and COVID-19 Clinical Research Studies (3 papers). Massimo Mattioli is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Systemic Sclerosis and Related Diseases (5 papers) and COVID-19 Clinical Research Studies (3 papers). Massimo Mattioli collaborates with scholars based in Italy, United Kingdom and Australia. Massimo Mattioli's co-authors include Devis Benfaremo, Armando Gabrielli, Giovanni Pomponio, Paolo Fraticelli, Elia Vettore, Andrea Dalbeni, Roberto Serra, Paolo Angeli, Lorenzo Cerruti and Fausto Salaffi and has published in prestigious journals such as Annals of the Rheumatic Diseases, Obesity Reviews and Medicine.

In The Last Decade

Massimo Mattioli

14 papers receiving 240 citations

Peers

Massimo Mattioli
Massimo Mattioli
Citations per year, relative to Massimo Mattioli Massimo Mattioli (= 1×) peers Şermin Börekçi

Countries citing papers authored by Massimo Mattioli

Since Specialization
Citations

This map shows the geographic impact of Massimo Mattioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Mattioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Mattioli more than expected).

Fields of papers citing papers by Massimo Mattioli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Mattioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Mattioli. The network helps show where Massimo Mattioli may publish in the future.

Co-authorship network of co-authors of Massimo Mattioli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Mattioli. A scholar is included among the top collaborators of Massimo Mattioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Mattioli. Massimo Mattioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mattioli, Massimo, et al.. (2022). Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study. Clinical and Experimental Emergency Medicine. 9(1). 10–17. 3 indexed citations
2.
Cicco, Sebastiano, Marco D’Abbondanza, Marco Proietti, et al.. (2022). Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients. European Journal of Clinical Investigation. 53(4). e13931–e13931. 2 indexed citations
3.
Mattioli, Massimo, et al.. (2020). Safety of intermediate dose of low molecular weight heparin in COVID-19 patients. Journal of Thrombosis and Thrombolysis. 51(2). 286–292. 35 indexed citations
4.
Benfaremo, Devis, et al.. (2020). Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19). Seminars in Thrombosis and Hemostasis. 46(7). 856–858. 10 indexed citations
5.
Mattioli, Massimo, et al.. (2020). Heart transplant recipient patient with COVID‐19 treated with tocilizumab. Transplant Infectious Disease. 22(6). e13380–e13380. 9 indexed citations
6.
Piano, Salvatore, Andrea Dalbeni, Elia Vettore, et al.. (2020). Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19. Liver International. 40(10). 2394–2406. 96 indexed citations
7.
Mattioli, Massimo, et al.. (2020). Unusual cause of back pain and dysphagia: a Kommerell aneurysm. BMJ Case Reports. 13(8). e237337–e237337. 1 indexed citations
8.
Bonifazi, Martina, Nicola Sverzellati, Eva Negri, et al.. (2019). Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry. Lara D. Veeken. 59(3). 641–649. 15 indexed citations
9.
Fraticelli, Paolo, Fausto Salaffi, Marina Carotti, et al.. (2019). Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study.. PubMed. 36 Suppl 113(4). 142–145. 41 indexed citations
11.
Bonifazi, Martina, et al.. (2017). SAT0353 Small airways involvement in scleroderma patients: results of a case-control study. Annals of the Rheumatic Diseases. 76. 905–905. 1 indexed citations
12.
Fraticelli, Paolo, et al.. (2017). A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA).. PubMed. 35 Suppl 106(4). 173–178. 5 indexed citations
13.
Fraticelli, Paolo, et al.. (2016). Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib. World Journal of Clinical Cases. 4(10). 328–328. 5 indexed citations
14.
Fraticelli, Paolo, et al.. (2015). FRI0485 Preliminary Analysis of a Cohort of Patients with Systemic Sclerosis Treated with Rituximab and Mycophenolate Mofetil. Annals of the Rheumatic Diseases. 74. 604–604.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026